Nano-Hydroxyapatite Doped with Ho-166 as Drug Delivery System for Bone Cancer Therapy and Diagnosis: Developing a Theragnostic Radiopharmaceuticals.
The use of nanobiomaterials is increasing each day. Among the immense variety of nanomaterials developed and studied the hydroxyapatite is one of the most ones. In this study we developed and tested nano-hydroxyapatite dopped with Ho-166 for bone cancer. The results showed that the nano-hydroxyapatite dopped with Ho-166 has a great affinity for the bone. The pre-clinical studies support the use as a nano-radiopharmaceuticals for bone cancer treatment and diagnosis.